Get started

Bioconbreakout

Biocon cmp 398.75 by Weekly Chart viewBiocon cmp 398.75 by Weekly Chart view - Support Zone at 340 to 365 Price Band - Resistance Zone at 400 to 425 Price Band - 2nd Falling Resistance Trendline Breakout attempted - 1st Falling Resistance Trendline Breakout done and sustained - Stock Price restrained below Resistance Zone after ATH 487.75 in Dec 2020 - Volumes seen galloping heavily and surging well above the avg traded quantity - Multiple Bullish Technical patterns completed under Resistance Zone Price Band - *SUBJECT TO*..... Resistance Zone crossover by few days sustained closure, *ONLY then FRESH BREAKOUT* maybe expected*
NSE:BIOCON
by PIYUSHCHAVDA
Putting Price Action Altogether | BIOCON LIMITED ⚡️ Investing opportunity: Price Action Analysis Alert !!!⚡️ ⚠️Education Purpose only!!!! 1️⃣Biocon Limited Overview 📍Founded: 1978 by Kiran Mazumdar-Shaw 📍Headquarters: Bengaluru, Karnataka, India 📍Markets: Over 120 countries, including the United States and Europe 2️⃣Key Business Divisions 👉Generics: Produces generic APIs for global markets. 👉Biosimilars: Focuses on biosimilar insulins and monoclonal antibodies. 👉Research Services: Contract research and development via subsidiary Syngene International. 👉Novel Biologics: Develops innovative therapies for diseases like cancer, diabetes, and autoimmune disorders. 3️⃣Financial Performance ✅Net Loss: ₹160 million ✅Revenue: ₹35.9 billion, up 3.7% YoY. ✅Biosimilars Revenue: Increased by 11% (U.S., Europe). ✅Generics Revenue: Declined by 7.7% 4️⃣Technical Reasons to trade or Strategy applied :- ⭕️50 Day Moving averages shows strong Bullishness in Long-Term ⭕️Head&Shoulder Pattern Breakout ⭕️Breakout with strong Volume ⭕️Channel Pattern Formation ⭕️Upward Trendline for Resistance ⭕️Higher-Lows Formation before Breakout ⭕️Trendline Breakout too 5️⃣Key Takeaways ⚠️Strengths: Strong global presence and diverse biopharmaceutical portfolio. ⚠️Challenges: Recent profitability concerns due to pricing pressures and tax adjustments. ⚠️Growth Potential: Biosimilars and novel biologics present significant long-term opportunities. ⚠️Investor Consideration: Combine fundamental and technical analyses to assess investment decisions. ✅Check out my Trading View profile to see how we analyze charts and execute trades. 🙋‍♀️🙋‍♂️If you have any questions about this stock, feel free to reach out to me. 📍📌Thank you for exploring our idea! We hope you found it valuable. 🙏FLLOW for more ! 👍LIKE if useful ! ✍️COMMENT Below your view
NSE:BIOCON
by ReviveTraders